Akums Drugs and Pharmaceuticals has released its financial results for the quarter and year ended March 31, 2026. The Board of Directors has recommended a total dividend of ₹3.00 per share, comprising a ₹1.00 final dividend and a ₹2.00 special dividend. The company also announced key senior management changes and set the Annual General Meeting for July 10, 2026, while maintaining a positive outlook despite ongoing tax proceedings.
Financial Highlights
For the fiscal year ended March 31, 2026, the company reported consolidated revenue from operations of ₹43,590.17 million, compared to ₹41,181.58 million in the previous year. The consolidated net profit for the year stood at ₹2,563.97 million. On a standalone basis, the company reported an annual revenue of ₹13,487.36 million and a net profit of ₹1,116.40 million.
Dividend Recommendation
Reflecting the company’s commitment to shareholder value, the Board has recommended a final dividend of ₹1.00 per share and a special dividend of ₹2.00 per share for the financial year ended March 31, 2026. The record date for determining shareholder eligibility for the dividend payment has been fixed for July 3, 2026, subject to approval at the 22nd Annual General Meeting.
Leadership Changes
The company announced strategic changes within its senior management team effective May 14, 2026. Mr. V Jagannathan has been appointed as the new President – HR, taking over from Mr. Arvind Srivastava, who is stepping down from the role due to organizational structural changes.
Operational Updates
The company continues to cooperate with tax authorities regarding search and seizure proceedings initiated in early 2025. Management has confirmed that despite these ongoing proceedings, there have been no demands raised to date, and they do not anticipate the need for material financial adjustments based on their current assessment and legal advice.
Annual General Meeting
The 22nd Annual General Meeting is scheduled to be held on Friday, July 10, 2026, at 11:00 AM IST. The meeting will be conducted through video conferencing and other audio-visual means, allowing for broader shareholder participation.
Source: BSE
